Experimental Keratitis Due to Pseudomonas aeruginosa: Model for Evaluation of Antimicrobial Drugs
AUTOR(ES)
Davis, Starkey D.
RESUMO
An improved method for experimental keratitis due to Pseudomonas aeruginosa is described. Essential features of the method are use of inbred guinea pigs, intracorneal injection of bacteria, subconjunctival injection of antibiotics, “blind” evaluation of results, and statistical analysis of data. Untreated ocular infections were most severe 5 to 7 days after infection. Sterilized bacterial suspensions caused no abnormalities on day 5. Tobramycin and polymyxin B were more active than gentamicin against two strains of Pseudomonas. This model is suitable for many types of quantitative studies on experimental keratitis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=429317Documentos Relacionados
- Pseudomonas aeruginosa LasA Protease in Treatment of Experimental Staphylococcal Keratitis
- Temperature-sensitive mutants of Pseudomonas aeruginosa: isolation and preliminary immunological evaluation.
- Penicillin-Resistant Mechanisms in Pseudomonas aeruginosa: Binding of Penicillin to Pseudomonas aeruginosa KM 338
- Experimental Pseudomonas aeruginosa Keratitis in Interleukin-10 Gene Knockout Mice
- Chemotaxis of Pseudomonas aeruginosa: involvement of methylation.